Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

COPD patients benefit from TAVR—but there are some significant risks to consider

When discussing the possibility of TAVR for a patient with COPD, it is crucial to consider the severity of their symptoms.  

PSMA PET mapping improves radiation therapy contouring after PCA recurrence

Salvage radiation therapy guidelines for patients with prostate cancer recurrence need to be updated to include findings identified on PSMA PET, according to new research shared at SNMMI’s annual conference this week. 

Multimodality imaging turns up serial thromboses following AstraZeneca COVID vaccination

Whole-body imaging reveals clinically undetectable blood clots in patients after their first dose of AstraZeneca's COVID vaccine.

The Corvia Atrial Shunt is designed to address elevated left atrial pressure (LAP) heart failure patients.

Corvia Medical raises $54M to continue studying implantable heart failure treatment

The company will use the funds to follow up on what it learned from the REDUCE LAP-HF II clinical trial.

New insights into what causes cardiac hypertrophy—and how to treat it

“We have finally been able to pinpoint one of the key reasons why the heart muscle wall thickens," one researcher said. 

Thumbnail

Seeing the future: How routine eye exams could predict heart attacks

Researchers presented their findings at the 2022 European Human Genetics Conference in Vienna. 

Transcatheter mitral valve repair (TMVr) is associated with “promising” short-term outcomes among patients with a history of cancer, according to new research published in the American Journal of Cardiology.

'Promising' new data on TMVr among cancer patients

The study's authors examined data from nearly 23,000 patients who underwent transcatheter mitral valve repair from 2014 to 2018. 

Thumbnail

TAVR vs. surgery among children and young adults with congenital heart disease

Though TAVR was once never considered a treatment option for younger patients, it is becoming more common as time goes on.